Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Interchange of vaccine products
Clinical narrative: COVID-19/symptoms returned and tested positive for covid again; Interchange of vaccine products; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19/symptoms returned and tested positive for covid again) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer / BioNTech (Dose Number: 1 Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion Location of injection: Arm Left.) on 31-Mar-2021 and Pfizer / BioNTech (Dose Number: 2 Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion Location of injection: Arm Left.) on 21-Apr-2021. Past adverse reactions to the above products included No adverse reaction with Pfizer / BioNTech and Pfizer / BioNTech. Concurrent medical conditions included Postural orthostatic tachycardia syndrome (postural tachycardia) and Drug allergy. Concomitant products included PROPRANOLOL for an unknown indication.    On 21-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19/symptoms returned and tested positive for covid again) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 10-May-2022 to 14-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19/symptoms returned and tested positive for covid again) had not resolved and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown.            It was reported that after Paxlovid treatment patient tested covid negative on days 5, 6, 7, 8. On day 10 symptoms returned and tested positive for covid again. Currently day 14 and still positive.  Company comment: This is a spontaneous case reported by a consumer. A patient of an unknown age and gender, previously vaccinated with 2 doses of Pfizer, experienced non serious event of COVID-19 (AESI) after receiving mRNA-1273 vaccine, reported as the third dose of the COVID-19 vaccination schedule. Onset date of the event was not provided. Patient was treated with Paxlovid with negative tests on days 5, 6, 7, 8; on day 10 symptoms returned and tested positive again. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case reported by a consumer. A patient of an unknown age and gender, previously vaccinated with 2 doses of Pfizer, experienced non serious event of COVID-19 (AESI) after receiving mRNA-1273 vaccine, reported as the third dose of the COVID-19 vaccination schedule. Onset date of the event was not provided. Patient was treated with Paxlovid with negative tests on days 5, 6, 7, 8; on day 10 symptoms returned and tested positive again. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.